181 related articles for article (PubMed ID: 26522061)
1. Association of intensity-modulated radiation therapy on overall survival for patients with Hodgkin lymphoma.
Parikh RR; Grossbard ML; Harrison LB; Yahalom J
Radiother Oncol; 2016 Jan; 118(1):52-9. PubMed ID: 26522061
[TBL] [Abstract][Full Text] [Related]
2. Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma.
Filippi AR; Ciammella P; Piva C; Ragona R; Botto B; Gavarotti P; Merli F; Vitolo U; Iotti C; Ricardi U
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):370-5. PubMed ID: 24613810
[TBL] [Abstract][Full Text] [Related]
3. Evolution of radiation techniques in the treatment of mediastinal lymphoma: from 3D conformal radiotherapy (3DCRT) to intensity-modulated RT (IMRT) using helical tomotherapy (HT): a single-centre experience and review of the literature.
Besson N; Pernin V; Zefkili S; Kirova YM
Br J Radiol; 2016; 89(1059):20150409. PubMed ID: 26744079
[TBL] [Abstract][Full Text] [Related]
4. Local Therapy Improves Overall Survival in Patients With Newly Diagnosed Metastatic Prostate Cancer.
Parikh RR; Byun J; Goyal S; Kim IY
Prostate; 2017 May; 77(6):559-572. PubMed ID: 28093791
[TBL] [Abstract][Full Text] [Related]
5. Early-Stage Classic Hodgkin Lymphoma: The Utilization of Radiation Therapy and Its Impact on Overall Survival.
Parikh RR; Grossbard ML; Harrison LB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):684-93. PubMed ID: 26279323
[TBL] [Abstract][Full Text] [Related]
6. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy.
Pinnix CC; Cella L; Andraos TY; Ayoub Z; Milgrom SA; Gunther J; Thosani S; Wogan C; Conson M; D'Avino V; Oki Y; Fanale M; Lee HJ; Neelapu S; Fayad L; Hagemeister F; Rodriguez MA; Nastoupil LJ; Nieto Y; Qiao W; Pacelli R; Dabaja B
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):530-540. PubMed ID: 29681481
[TBL] [Abstract][Full Text] [Related]
8. Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base.
Jegadeesh N; Liu Y; Gillespie T; Fernandez F; Ramalingam S; Mikell J; Lipscomb J; Curran WJ; Higgins KA
Clin Lung Cancer; 2016 Sep; 17(5):398-405. PubMed ID: 26936682
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: A National Cancer Data Base study.
Elson JK; Kachnic LA; Kharofa JR
Cancer; 2018 Nov; 124(22):4383-4392. PubMed ID: 30329160
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
[TBL] [Abstract][Full Text] [Related]
11. Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities.
Chen NB; Qiu B; Zhang J; Qiang MY; Zhu YJ; Wang B; Guo JY; Cai LZ; Huang SM; Liu MZ; Li Q; Hu YH; Li QW; Liu H
Cancer Res Treat; 2020 Jan; 52(1):31-40. PubMed ID: 31048664
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiotherapy at high-volume centers improves survival in patients with esophageal adenocarcinoma receiving trimodality therapy.
Yang GQ; Mhaskar R; Rishi A; Naghavi AO; Frakes JM; Almhanna K; Fontaine J; Pimiento JM; Hoffe SE
Dis Esophagus; 2019 Aug; 32(8):. PubMed ID: 30597022
[TBL] [Abstract][Full Text] [Related]
13. Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy?
De Sanctis V; Bolzan C; D'Arienzo M; Bracci S; Fanelli A; Cox MC; Valeriani M; Osti MF; Minniti G; Chiacchiararelli L; Enrici RM
Radiat Oncol; 2012 Aug; 7():129. PubMed ID: 22857015
[TBL] [Abstract][Full Text] [Related]
14. A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer.
Harris JP; Murphy JD; Hanlon AL; Le QT; Loo BW; Diehn M
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):872-84. PubMed ID: 24495591
[TBL] [Abstract][Full Text] [Related]
15. Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803--a report from the Children's Oncology Group.
Lin C; Donaldson SS; Meza JL; Anderson JR; Lyden ER; Brown CK; Morano K; Laurie F; Arndt CA; Enke CA; Breneman JC
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1764-70. PubMed ID: 21470795
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
[No Abstract] [Full Text] [Related]
17. Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer.
Lin SH; Wang L; Myles B; Thall PF; Hofstetter WL; Swisher SG; Ajani JA; Cox JD; Komaki R; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1078-85. PubMed ID: 22867894
[TBL] [Abstract][Full Text] [Related]
18. Comparative outcomes for three-dimensional conformal versus intensity-modulated radiation therapy for esophageal cancer.
Freilich J; Hoffe SE; Almhanna K; Dinwoodie W; Yue B; Fulp W; Meredith KL; Shridhar R
Dis Esophagus; 2015; 28(4):352-7. PubMed ID: 24635657
[TBL] [Abstract][Full Text] [Related]
19. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy modality as a predictor of survival in hypopharyngeal cancer.
Kılıç S; Kılıç SS; Hsueh WD; Eloy JA; Baredes S; Woo Park RC; Mahmoud O
Head Neck; 2018 Nov; 40(11):2441-2448. PubMed ID: 30306665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]